The University of North Carolina at Chapel Hill (UNC-CH) was awarded a $268,401 Project Grant under the National Cancer Institute's (NCI) Cancer Research Manpower (CFDA 93.398) program. The grant, effective July 3, 2024 through June 30, 2029, will fund the Cancer Undergraduate Research Education Program (CUREP). This program aims to address the underrepresentation of Black Americans and other economically disadvantaged groups in cancer research by expanding and diversifying the pool of future...
The National Cancer Institute (NCI) awarded a $118,687 Project Grant under the Cancer Research Manpower (CFDA 93.398) federal grant program to the University of Florida. The grant will fund the "THE FLORIDA SUMMER TRAINING IN RESEARCH AND ONCOLOGY FOR THE NEXT GENERATION OF RESEARCHERS (STRONGER) PROGRAM" which aims to provide 8 undergraduate students from non-R1 universities, including Historically Black Colleges and Universities and Hispanic-Serving Institutions, with hands-on cancer...
This Project Grant award of $315,143.00 from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) supports clinical trial research in the oncology landscape. The award, which has an ultimate completion date of August 31, 2029, is being provided to The Ohio State University, a leading public research university. Through this funding, The Ohio State University will conduct innovative cancer research focused on understanding cancer mechanisms, developing new diagnostic and...
The U.S. Department of Health and Human Services, National Institutes of Health (NIH) awarded a $388,712 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Dana-Farber Cancer Institute (DFCI) in Boston, MA. The "Young Empowered Scientists for Continued Research Engagement (YES for CURE)" program aims to increase participation and retention of underrepresented minority students in cancer-related STEM fields. The multi-year program will provide high school...
The University of Oklahoma (OU) was awarded a $1,051,250 Project Grant from the Defense Health Agency to conduct research on the re-expression of miR-195 as a therapeutic strategy for chemoresistant ovarian cancer. This research falls under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform health care for service members and the American public. The project is scheduled to run from August 15, 2023, to August 14, 2027. As a public...
The National Cancer Institute (NCI) awarded Emory University a $312,737 Project Grant under the Cancer Research Manpower (CFDA 93.398) federal grant program. The "Georgia Science Education Initiative NCI YES (GA-YES)" program aims to recruit and train high school students underrepresented in STEM careers, with a focus on rural and lower socioeconomic status students, in cancer research and disparities. Key program components include: 1) a summer mentored cancer research training...
The University of Wisconsin-Madison received a $307,680 Project Grant award from the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) federal grant program. The purpose of this 5-year grant, awarded on July 30, 2025, is to establish the Academic Summer Student Undergraduate Research Experience (ASSURE) program in advanced radiological sciences. ASSURE aims to equip future cancer researchers with the scientific and technological skills to harness emerging...
The University of Cincinnati is the recipient of a $383,491 Project Grant from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) to establish a Training Program in Basic and Translational Oncology. The goal of the 5-year program is to increase the number of researchers capable of bridging the divide between cancer biology research and clinical application, with a focus on cancer metabolism, tumor immunology, and translational cancer therapy. The program will provide...
The National Cancer Institute (NCI) awarded a $178,444 Project Grant under the Cancer Research Manpower (CFDA 93.398) federal grant program to the University of California, Los Angeles (UCLA) for the "UCLA SURGEON-SCIENTIST BASIC CANCER RESEARCH TRAINING PROGRAM (UCLA SURGEON-SCIENTIST BCRTP)". The program aims to provide rigorous curriculum and mentored research experiences to exceptional surgical residents dedicated to advancing cancer research and treatment innovation. The program...
This $1,144,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Oklahoma Health Sciences Center to develop a drug targeting ORP4 as a precision treatment for ovarian cancer. The research aims to transform healthcare for military service members, veterans, and the broader public through innovative investigations spanning basic, applied, and translational domains....
The University of Oklahoma Health Sciences Center was awarded a $211,628 Project Grant under the National Cancer Institute's (NCI) Cancer Research Manpower (CFDA 93.398) program. The 5-year grant, effective August 1, 2025, will fund the "Cancer Undergraduate Research Experience (CURE) in Oklahoma" program.
The key objectives of the CURE program are to: 1) Deliver high-quality cancer research training experiences for undergraduate students under the mentorship of 53 participating researchers, 2) Provide a comprehensive educational and career development curriculum in cancer research, and 3) Implement a robust program evaluation to assess both short-term and long-term outcomes, such as student matriculation into graduate programs and future careers in cancer research. This program aims to build a pipeline of students equipped with cancer research expertise to address Oklahoma's high cancer incidence and mortality rates compared to national averages.